Actively Recruiting
Finding Alternatives to Standard Treatment for Attention-Deficit Hyperactivity Disorder
Led by University of Calgary · Updated on 2026-05-14
30
Participants Needed
1
Research Sites
95 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Attention-Deficit/Hyperactivity Disorder (ADHD) is characterized by poor attention, impulsivity, hyperactivity and emotional-motivational dysregulation. Here, we will test if theta burst repetitive transcranial magnetic stimulation (rTMS) can reduce the symptoms of ADHD.
CONDITIONS
Official Title
Finding Alternatives to Standard Treatment for Attention-Deficit Hyperactivity Disorder
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of ADHD
- Age between 9 and 15 years
- IQ greater than 80
- Fluent in English to enable consent or assent
- If on medication, must have been on the same type and dosage for at least 3 months
You will not qualify if you...
- Diagnosis of mania, psychosis, or bipolar disorder
- Any impediment to TMS or MRI, such as metal implants in the body
- Prior treatment with electroconvulsive therapy or vagus nerve stimulation
- Diagnosis of Autism Spectrum Disorder
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Alberta Children's Hospital
Calgary, Alberta, Canada, T3B 6A8
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here